title: Targeted agents for advanced thyroid cancer: "knowledge is power" - the role of multikinase inhibitors.
authors.affiliation: 1st Department of General Surgery Ospedale di Circolo e Fondazione Macchi Varese, Insubria University Varese-Como, Varese, Italy.
authors.forename: Alberto
authors.initials: A
authors.lastname: Mangano
authors.forename: Hoon Yub
authors.initials: HY
authors.lastname: Kim
authors.forename: Georgios D
authors.initials: GD
authors.lastname: Lianos
authors.forename: Dimitrios H
authors.initials: DH
authors.lastname: Roukos
authors.forename: Gianlorenzo
authors.initials: G
authors.lastname: Dionigi
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D058990:Molecular Targeted Therapy; D010770:Phosphotransferases / Q000037:antagonists & inhibitors*; D013964:Thyroid Neoplasms / Q000188:drug therapy* / Q000378:metabolism*
chemical_list: D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D010770:Phosphotransferases
keywords: advanced thyroid cancer; intertumor heterogeneity; intratumor heterogeneity; multikinase inhibitor; targeted agent